700 related articles for article (PubMed ID: 23868476)
1. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
[TBL] [Abstract][Full Text] [Related]
2. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis.
Castro G; Azrak MF; Seeff LC; Royalty J
Cancer; 2013 Aug; 119 Suppl 15():2849-54. PubMed ID: 23868479
[TBL] [Abstract][Full Text] [Related]
3. Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.
Seeff LC; DeGroff A; Joseph DA; Royalty J; Tangka FK; Nadel MR; Plescia M
Cancer; 2013 Aug; 119 Suppl 15():2940-6. PubMed ID: 23868488
[TBL] [Abstract][Full Text] [Related]
4. Lessons learned from the CDC's Colorectal Cancer Screening Demonstration Program.
Seeff LC; Rohan EA
Cancer; 2013 Aug; 119 Suppl 15():2817-9. PubMed ID: 23868475
[TBL] [Abstract][Full Text] [Related]
5. Delivering colonoscopy screening for low-income populations in Suffolk County: strategies, outcomes, and benchmarks.
Lane DS; Messina CR; Cavanagh MF; Anderson JC
Cancer; 2013 Aug; 119 Suppl 15():2842-8. PubMed ID: 23868478
[TBL] [Abstract][Full Text] [Related]
6. Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.
Nadel MR; Royalty J; Shapiro JA; Joseph D; Seeff LC; Lane DS; Dwyer DM
Cancer; 2013 Aug; 119 Suppl 15(0 15):2834-41. PubMed ID: 23868477
[TBL] [Abstract][Full Text] [Related]
7. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
[TBL] [Abstract][Full Text] [Related]
8. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
Webendörfer S; Riemann JF
Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
[TBL] [Abstract][Full Text] [Related]
9. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
11. Collaborating across multiple health care institutions in an urban colorectal cancer screening program.
Villanueva R; Gugel D; Dwyer DM
Cancer; 2013 Aug; 119 Suppl 15():2905-13. PubMed ID: 23868485
[TBL] [Abstract][Full Text] [Related]
12. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
13. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
Tangka FK; Subramanian S; Beebe MC; Hoover S; Royalty J; Seeff LC
Cancer; 2013 Aug; 119 Suppl 15(0 15):2863-9. PubMed ID: 23868481
[TBL] [Abstract][Full Text] [Related]
14. Use of colorectal cancer tests--United States, 2002, 2004, and 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):253-8. PubMed ID: 18340331
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
16. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
Loss J; Eichhorn C; Nagel E
Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
[TBL] [Abstract][Full Text] [Related]
17. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.
Subramanian S; Tangka FKL; Hoover S; Royalty J; DeGroff A; Joseph D
Eval Program Plann; 2017 Jun; 62():73-80. PubMed ID: 28190597
[TBL] [Abstract][Full Text] [Related]
18. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
19. Trends in screening for colorectal cancer--United States, 1997 and 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(9):162-6. PubMed ID: 11393486
[TBL] [Abstract][Full Text] [Related]
20. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
